The Next 10 Years To Dictate Growth Of Aquaculture Feed And Pharmaceutical Market Based On Organic Expansion (Reaching US$ 800 Million)

The Aquaculture Feed And Pharmaceutical Market is bound to reach US$ 800 Million at a CAGR of 7.3% between 2025. The modern-day situation says that the healthcare sector is witnessing an optimization and reposition of the business models to obtain enhanced patient outcomes. With real-time analytics known to improve patient care and the fact that consumers are shifting towards the preventive model of care, the healthcare vertical is likely to witness greater strides in the forecast period.

A recent report published by Persistence Market Research prognosticates that the global market for aquaculture feed and pharmaceuticals would be valued at US$1,068.9 mn by 2025 registering a CAGR of 7.3% over 2017-2025.

The report, titled “Aquaculture Feed and Pharmaceutical Market: Global Industry Analysis 2012–2016 and Forecast 2017–2025,” portrays that the cumulative revenue generated by the market is projected to increase 1.8X over the forecast period from 2017-2025.

Planning Forward? Access Sample Of Aquaculture Feed And Pharmaceutical Market Report! https://www.persistencemarketresearch.co/samples/13387

Company Profiles 

• Zoetis, Inc.
• Schouw & Co
• Ridley Corporation Ltd
• Merck & Co Inc
• Biomin Holding GmbH
• Aller Aqua A/S
• Nutriad Ltd.
• Alltech Inc.
• Avanti Feeds Ltd.
• Norel S.A.
• Cargill, Incorporated
• Beneo GmbH
• Skretting AS
• Novus International Inc.
• Growel Feeds Pvt. Ltd.
• Neovia Vietnam
• Evonik Industries AG
• Bayer AG
• Koninklijke DSM N.V
• Others.

The paced development of new vaccines for aqua life and a rampant rise in the number of market players in this segment, especially in the developed countries like the U.S. and Canada, has augmented the global market for aquaculture feed and pharmaceuticals.

The global aquaculture feed and pharmaceutical market is categorized in the report on the basis of product types into pharmaceuticals and biologics and medicated feed. Of these, the segment of pharmaceuticals and biologics is expected to be the dominating one in terms of revenue, registering a CAGR of 7.7% over 2017-2025 to outdo all other product types.

Over the forecast period medicated feed is approximated to reach a CAGR of 6.6% in terms of revenue. On the front of market segmentation by species, shrimps and carps would fare the highest CAGR of 7.7% over 2017-2025.

On a geographical footing, Asia Pacific is forecasted to exhibit the highest CGPA of 7.6% amongst all other regional markets including Latin America, North America, Europe, and Middle East and Africa (MEA). Inland aquaculture is the most distinct avenue for the industry in Asia pacific and 66.6% fish is produced inland.

How About Revitalizing The Strategy-Oriented Funnel To Stay Ahead In The Aquaculture Feed And Pharmaceutical Market? https://www.persistencemarketresearch.co/methodology/13387

The most prominent driver that has propelled the global market for aquaculture feed and pharmaceuticals is the growing demand for R&D in the field. This has further eased the entry of drugs, medicated feed, and vaccines in regional markets of developed nations like the United States of America and Canada.

Owing to this, the aquaculture feed and pharmaceuticals industry has inorganically grown by liaising with key players. Moreover, if certain guidelines and compliance standards are met, there is no restriction on the use of extra-label drugs in the U.S., which could further fortify the market.

Measures to immune fishes against diseases is also a substantially effectual driver. Alongside this, aquaculture has become a vital source of food for human consumption, because of which various government initiatives are aiming to rid aqua life of the menace of diseases.

Planning To Introduce An Offbeat Product/Technology In The Aquaculture Feed And Pharmaceutical Market? Go To “Purchase Now” To Have Our Aquaculture Feed And Pharmaceutical Market Report! https://www.persistencemarketresearch.com/checkout/13387

The production of veterinary medicines and medicated feed is governed by different laws and policies across different countries. Each country is deemed to adhere to their production standards, which makes it difficult to forecast trends and estimate figures. Moreover, most veterinary treatments are relatively expensive, which discourage people from cultivating aquaculture.

The instances of lack of proper treatment and inability to diagnose diseases is also a shortfall for the aquaculture feed and pharmaceuticals market.

The growth of regional players in the market for aquaculture feed and pharmaceuticals has prompted the big companies to collaborate with them and reap the benefits of access to a larger set of consumers. There also lies an opportunity for market players to acquire regional players and thus optimize market share.

Access Trending Reports:

Animal Parasiticide Market – In terms of revenue, the global animal parasiticides market is estimated to register a promising CAGR of 5.9% over the forecast period, owing to numerous factors, about which PMR offers thorough insights and forecasts in this report.

Alginate Dressings Market – The global alginate dressings market is projected to be valued at US$ 1.1 Bn in 2030, and is expected to exhibit a CAGR of 3.5% during the forecast period (2020 – 2030).

Neurovascular Thrombectomy Devices Market – The neurovascular thrombectomy devices market by product type is expected to be dominated by the stent retriever segment due to their increasing adoption by healthcare professionals.

About Us :-

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact Information:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007, United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353